Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Nova Ltd — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B), while Nova Ltd trades at $352.95 (market cap $11.28B). The key difference: Nova Ltd is far larger — about 6.5× Nuvation Bio Inc. Class A Common Stock's market cap, and Nova Ltd is more actively traded (394,997 versus 9,289,619). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Nova Ltd for 4 Days on average.
| NUVB | NVMI | |
|---|---|---|
Market Cap | $1.74B | $11.28B |
Volume | 9,289,619 | 394,997 |
Sector | Health | Technology |
52-Week High | $9.54 | $605.65 |
52-Week Low | $3.41 | $275.78 |
Typical Hold Time | 1 Days | 4 Days |
Enterprise Value | $1.33B | $11.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
